Sarah Siraj
Overview
Explore the profile of Sarah Siraj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siraj S, Masoodi T, Siraj A, Azam S, Qadri Z, Parvathareddy S, et al.
Cancers (Basel)
. 2022 Mar;
14(6).
PMID: 35326735
Standard surgery followed by radioactive iodine (131I, RAI) therapy are not curative for 5−20% of papillary thyroid carcinoma (PTC) patients with RAI refractory disease. Early predictors indicating therapeutic response to...
2.
Pratheeshkumar P, Siraj A, Divya S, Parvathareddy S, Siraj S, Diaz R, et al.
Cancers (Basel)
. 2021 Jan;
13(2).
PMID: 33430300
The Krüppel-like factor 5 (KLF5), a zinc-finger transcriptional factor, is highly expressed in several solid tumors, but its role in PTC remains unclear. We investigated the expression of KLF5 protein...
3.
Siraj A, Pratheeshkumar P, Divya S, Parvathareddy S, Alobaisi K, Thangavel S, et al.
Front Pharmacol
. 2021 Jan;
11:598880.
PMID: 33424607
Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy. Despite current therapeutic and surgical options, advanced EOC shows poor prognosis. Identifying novel molecular therapeutic targets is highly needed in...
4.
Siraj S, Masoodi T, Siraj A, Azam S, Qadri Z, Ahmed S, et al.
Cancers (Basel)
. 2020 Oct;
12(10).
PMID: 33053768
Colorectal cancer (CRC) is the third most frequently diagnosed cancer worldwide, where ~50% of patients develop metastasis, despite current improved management. Genomic characterisation of metastatic CRC, and elucidating the effects...
5.
Masoodi T, Siraj S, Siraj A, Azam S, Qadri Z, Parvathareddy S, et al.
Br J Cancer
. 2020 Feb;
122(8):1219-1230.
PMID: 32099096
Background: High-grade serous ovarian carcinoma (HGSOC) is the most frequent type of ovarian carcinoma, associated with poor clinical outcome and metastatic disease. Although metastatic processes are becoming more understandable, the...
6.
Siraj A, Masoodi T, Bu R, Parvathareddy S, Siraj S, Alassiri A, et al.
Gut
. 2020 Jan;
69(11):2048-2049.
PMID: 31924657
No abstract available.
7.
Siraj A, Parvathareddy S, Bu R, Iqbal K, Siraj S, Masoodi T, et al.
Cancer Cell Int
. 2019 Dec;
19:334.
PMID: 31866764
Background: Endometrial carcinoma (EC) accounts for 5.8% of all cancers in Saudi females. Although most ECs are sporadic, 2-5% tend to be familial, being associated with Lynch syndrome and Cowden...
8.
Siraj A, Bu R, Iqbal K, Parvathareddy S, Siraj N, Siraj S, et al.
Genomics
. 2019 Nov;
112(2):1746-1753.
PMID: 31669704
Sanger Sequencing and immunohistochemistry was employed to investigate the TERT promoter mutations and TERT protein expression with their association to clinicopathological characteristics in over 2200 samples of Middle Eastern origin...
9.
Masoodi T, Siraj A, Siraj S, Azam S, Qadri Z, Parvathareddy S, et al.
Am J Hum Genet
. 2019 Nov;
105(5):959-973.
PMID: 31668701
Unlike many cancers, the pattern of tumor evolution in papillary thyroid cancer (PTC) and its potential role in relapse have not been elucidated. In this study, multi-region whole-exome sequencing (WES)...
10.
Masoodi T, Siraj A, Siraj S, Azam S, Qadri Z, Albalawy W, et al.
Thyroid
. 2019 Nov;
30(1):42-56.
PMID: 31668133
Distant metastasis is a rare occurrence in thyroid cancer, and it can be associated with poor prognosis. The genomic repertoires of various solid malignancies have previously been reported but remain...